# US 2013/0158248 A1 · Maleimide-furanyl compounds that can be used in a general method for preparing maleimide-oligonucleotide derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158248 A1
- Document ID: US20130158248A1
- Status: Published application
- Kind: A1
- Application number: 13/816,841
- Filed: 2011-05-02
- Published: 2013-06-20
- Earliest claimed: 2010-08-27
- Assignees: Universitat De Barcelona
- Inventors: Ana María Grandas Sagarra; Albert Sánchez González; Enrique Pedroso Muller
- Web page: https://patentgrep.com/patent/US20130158248A1

## CPC

- C07H 1/00: Processes for the preparation of sugar derivatives
- C07D 491/08: Bridged systems
- C07F 9/6561: containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The compounds of formula (I) substantially in exo form or salts thereof, wherein: X is a biradical selected from —(CH2)n—*, —(CH2CH2O)nCH2CH2—*, methylcyclohexyl and methylphenyl; n is an integer ranging between 1 and 30; Y is a radical selected from —COOH, a substituted phosphoramidite radical and N-hydroxysuccinimide ester (or other active ester) of carboxylic acid; and * represents the place through which X binds to Y, are useful in a general process for solid-phase preparation of maleimide-oligonucleotide derivatives.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

A compound of formula (I) substantially in exo configuration, or a salt thereof:
wherein:
X is a biradical selected from the group consisting of:
—(CH2)n—*, —(CH2CH2O)nCH2CH2—*,
n is an integer ranging between 1 and 30;
* represents the position through which X binds to Y;
Y is a radical selected from the group consisting of:
the wavy line representing the place through which Y binds to X;
PG is a phosphate protecting group; and
R1 and R2 are the same or different to each other and are selected from the group consisting of a C1-C10 alkyl radical and a morpholine radical.

### Claim 20 (depends on 19)

The compound of claim 19, wherein R1 and R2 are C1-C10 alkyl radicals.

### Claim 21 (depends on 19)

The compound of claim 19, wherein PG is selected from the group consisting of —CH2CH2CN, methyl, 2-cyano-1,1-dimethylethyl, and p-nitrophenylethyl.

### Claim 22 (depends on 19)

The compound of claim 19, wherein X is —(CH2)n—* or —(CH2CH2O)nCH2CH2—*, and wherein * has the same meaning as in claim 19.

### Claim 23 (depends on 19)

The compound of claim 19, wherein Y is —COOH or
and wherein the wavy line, PG, R1, and R2 have the same meaning as in claim 19.

### Claim 24 (depends on 19)

The compound of claim 19, being selected from the group consisting of compounds of formulae (Ia) and (Ib):

### Claim 25 (depends on 19)

A process for preparing the compound of formula (I) defined in claim 19 wherein Y is —COOH, the process comprising the steps of:
(a) carrying out a Diels-Alder reaction between a compound of formula (II) and a compound of formula (III),
wherein X has the same meaning as in claim 19, and
(b) carrying out a treatment of the compound obtained in step (a) with a nucleophilic base for isolating the compound of formula (I).

### Claim 26 (depends on 25)

The process of claim 25, wherein step (b) comprises the following substeps (b1) to (b4):
(b1) contacting a compound obtained in step (a) with a nucleophilic base at room temperature;
(b2) removing the nucleophilic base to obtain a resulting medium;
(b3) acidifying the resulting medium to a pH equal to or less than 3 to form a resulting product; and
(b4) isolating the resulting product.

### Claim 27 (depends on 25)

The process of claim 25, wherein the nucleophilic base is selected from ammonia, a primary amine, and a secondary amine.

### Claim 28 (depends on 19)

A process for preparing a compound of formula (I) defined in claim 19, wherein Y is
wherein the wavy line, PG, R1, and R2 have the same meaning as in claim 19, wherein the process comprises reacting a compound of formula (IV) with a compound of formula (V):
in an aprotic solvent and under anhydrous conditions,
wherein Z is selected from halogen and diisopropylamine, and
X has the same meaning as in claim 19.

### Claim 29 (depends on 19)

A process for solid-phase preparation of the maleimide-oligonucleotide derivative of formula (VI),
wherein X has the same meaning as in claim 19,
Y′ is selected from
wherein the wavy line represents the place through which Y′ binds to X, # represents the position through which Y′ binds to the oligonucleotide, and PG has the same meaning as in claim 19;
the process comprising the following steps:
(a) coupling the compound of formula (I), defined in claim 19, to an oligonucleotide that is immobilized on a solid support, for obtaining the compound of formula (VII)
wherein P is the solid support,
(b) releasing the compound of formula (VII), resulting from step (a), from the solid support to give rise to the compound of formula (VIII); and
(c) subjecting the compound of formula (VIII) to a retro-Diels-Alder reaction, such that the maleimide-oligonucleotide derivative of formula (VI) is obtained.

### Claim 30 (depends on 29)

The process of claim 29, wherein step (a) is carried out in the presence of pentafluorophenyl 4-nitrobenzenesulphonate and 1-hydroxybenzotriazole.

### Claim 31 (depends on 29)

The process of claim 29, wherein step (b) is carried out in the presence of a nucleophilic base.

### Claim 32 (depends on 29)

The process of claim 29, wherein step (c) is carried out with microwaves at a temperature in a range between 80-100° C.

### Claim 33 (depends on 29)

The process of claim 29, wherein step (c) is carried out by adding an aromatic hydrocarbon (C6-C8) to the compound of formula (VIII) resulting from step (b), and heating at a temperature in a range of from 80 to 100° C.

### Claim 34 (depends on 33)

The process of claim 33, wherein the aromatic hydrocarbon (C6-C8) is toluene.

### Claim 35 (depends on 29)

The process of claim 29, wherein:
step (b) is carried out in the presence of a nucleophilic base; and
step (c) is carried out by adding an aromatic hydrocarbon (C6-C8) to the compound of formula (VIII) resulting from step b), and heating with microwaves at a temperature in a range of from 80 to 100° C.

### Claim 36

A compound of formula (VII)
wherein
X is a biradical selected from the group consisting of:
—(CH2)n—*, —(CH2CH2O)nCH2CH2—*,
Y′ is selected from
the wavy line represents the place by which Y′ binds to X,
# represents the place through which Y′ binds to the oligonucleotide, and
P is a solid support.

### Claim 37

A compound of formula (VIII)
wherein
X is a biradical selected from the group consisting of:
—(CH2)n—*, —(CH2CH2O)nCH2CH2—*,
Y′ is selected from
the wavy line represents the place by which Y′ binds to X, and
# represents the place through which Y′ binds to the oligonucleotide.
